Keymed Biosciences: resultados de CMG901 presentados en el Simposio de Cánceres 2023 ASCO GI ...Middle East

News by : (PR Newswire) -
-Keymed Biosciences: últimos resultados del estudio clínico de fase Ia de CMG901 presentados en el Simposio de Cánceres 2023 ASCO GI CHENGDU, China, 19 de enero de 2023 /PRNewswire/ -- Keymed Biosciences Inc. (código bursátil: 02162 HK) se complace en anunciar que se presentarán los...

Hence then, the article about keymed biosciences resultados de cmg901 presentados en el simposio de canceres 2023 asco gi was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Keymed Biosciences: resultados de CMG901 presentados en el Simposio de Cánceres 2023 ASCO GI )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار